Recurrent Acute Leukemia of Ambiguous Lineage

specific

The reemergence of acute leukemia of ambiguous lineage after a period of remission.

Centers

Active Trials

—

Cancer Funding

Top Centers for Recurrent Acute Leukemia of Ambiguous Lineage(29)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
3	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
4	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
5	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
6	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
7	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
8	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
9	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
10	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
11	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
12	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
13	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	1	—	51.7
14	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
15	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
16	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	1	—	51.7
17	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
18	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	51.7
19	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
20	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	51.7
21	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	1	—	51.7
22	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	1	—	51.7
23	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	51.7
24	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	51.7
25	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	51.7
26	Livestrong Cancer InstitutesAustin, TX Active Research Program	Active Research Program	1	—	51.7
27	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	1	—	51.7
28	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	1	—	51.7
29	BC CancerVancouver, BC Active Research Program	Active Research Program	1	—	51.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →